Gibellini, Lara <br/><br/>
The protease inhibitor atazanavir triggers autophagy and mitophagy in human preadipocytes.  [electronic resource] 

 -  AIDS (London, England)  Oct 2012 
 - 2017-26 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-5571 
<br/><br/><label>Standard No.: </label>10.1097/QAD.0b013e328359b8be  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adipocytes--drug effects<br/>Anti-HIV Agents--pharmacology<br/>Antiretroviral Therapy, Highly Active<br/>Atazanavir Sulfate<br/>Autophagy--drug effects<br/>Blotting, Western<br/>Cells, Cultured<br/>Dose-Response Relationship, Drug<br/>Female<br/>Flow Cytometry<br/>Green Fluorescent Proteins--metabolism<br/>HIV Infections--drug therapy<br/>HIV Protease Inhibitors--pharmacology<br/>HIV-Associated Lipodystrophy Syndrome--drug therapy<br/>Humans<br/>Male<br/>Microscopy, Electron<br/>Mitophagy--drug effects<br/>Oligopeptides--pharmacology<br/>Pyridines--pharmacology